The Abortion Trap: How America's obsession with abortion hurts families everywhere
By Mara Hvistendahl,
Foreign Policy
| 07. 26. 2011
[Quotes CGS's Marcy Darnovsky]
For nearly two decades, anti-abortion activists have been at work in a disingenuous game, using the stark reduction of women in the developing world as an argument for taking away hard-earned rights. Conservative theorists have written openly about how sex-selective abortion is merely a convenient wedge issue in the drive to ban all abortions, both in the United States and abroad. And now, conservative commentators like the New York Times' Ross Douthat, the Wall Street Journal's Jonathan V. Last, and the editors of the New York Sun have claimed that my book, Unnatural Selection, strengthens their case.
This does not surprise me. One of the themes that cropped up again and again in my reporting was the extent to which American abortion politics on both sides of the question has stalled action on issues of major global importance. But it is deeply unfortunate. The American obsession with abortion does not just hinder work on maternal and child health or access to safe birth control abroad -- two areas that have suffered because of domestic campaigns by anti-abortion activists. It's also...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...